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Objective: To determine 30-day outcome and quality of life after elective endovascular abdominal aortic aneurysm repair
in octogenarians.
Methods: FromMarch 2009 toMay 2011, 1200 patients with abdominal aortic aneurysms were treated with endovascular
aneurysm repair (EVAR) using the Endurant stent graft were included in the Endurant Stent Graft Natural Selection
Global Postmarket Registry (ENGAGE) registry. Among these, 926 (77%) were aged <80 years, and 274 (23%) were
aged >80 years. Quality of life was assessed using composite EuroQoL 5-Dimensions Questionnaire index scores.
Results: Gender was unequally distributed, with more female patients among the octogenarians (P  .043). Octogenar-
ians had a significantly higher American Society of Anesthesiologists classification (P< .001) and differed significantly in
baseline risk factors. The younger cohort was more likely to smoke (P < .001) and be alcoholics (P  .005).
Octogenarians had larger aortic aneurysm (P .010) and left iliac artery diameters (P .017) and greater infrarenal neck
angulation (P .01). The technical success rate was>99% for both cohorts. Octogenarians were more often operated on
under general anesthesia (P  .028), had a longer procedure duration (P  .001), and an increased length of
hospitalization; both total (P < .001) and postprocedure (P < .001). All-cause mortality and major adverse event rates
were similar in the two groups (P .835 and P .186, respectively). There was no difference in the number of secondary
endovascular procedures or aneurysm rupture at 30 days. At discharge, both groups had reduced health status
dimensions, except anxiety/depression, when compared with baseline. At 30 days, the octogenarian group had a lower
composite EuroQoL 5-Dimensions Questionnaire index compared with the younger group, indicating a slower recovery
(0.83  0.20 vs 0.87  0.16; P  .003).
Conclusions: Octogenarians can be safely treated using the Endurant stent graft with a high technical rate of success, low
perioperative mortality, and no reduction in quality of life. Octogenarians did, however, appear to recover more slowly
than younger patients with respect to certain quality of life components. Long-term data are needed to confirm these
results. ( J Vasc Surg 2012;56:27-35.)
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aThere is a steady increase in life expectancy in industri-
alized countries. As abdominal aortic aneurysm (AAA) is an
age-related disease, more elderly patients, including octo-
and even nonagenarians, will be referred for AAA manage-
ment. Because open AAA repair in these age groups is
associated with high morbidity and mortality rates, endo-
vascular repair (EVAR) could potentially offer substantial
benefit. A systematic review of elective treatment of AAAs
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http://dx.doi.org/10.1016/j.jvs.2011.12.080n octogenarians has demonstrated acceptable survival rates
ith a perioperative mortality rate after open repair of
pproximately 7.5% (95% confidence interval [CI], 6.1-
.0) and a 5-year survival rate of 60%.1 In the group treated
y EVAR, the perioperative mortality rate was 4.6% (95%
I, 3.5-6.0). Long-term survival rates in both groups were
lso acceptable, but small sample size, selection, and pub-
ication bias had to be taken into account. Although the
oal of AAA repair is to prevent rupture, the risk of rupture
n this group with a limited life expectancy must be bal-
nced against the risk of the procedure. Further, one must
onsider effects on quality of life. Even if mortality rates are
cceptable, decrements in such issues as mobility and self-
are must be considered. The threshold age of 80 years
eems a good cutoff point for analysis because, although
rbitrary, current literature has used this cutoff in binary
nalyses.2-6
The Endurant Stent Graft Natural Selection Global
ostmarket Registry (ENGAGE) is a multicenter, nonin-
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July 201228 Pol et alterventional, nonrandomized, single-arm prospective study
of the Endurant stent graft device (Medtronic Cardiovas-
cular, Santa Rosa, Calif). These data provide a large data-
base to test the hypothesis that octogenarians may be safely
treated with EVAR while still providing acceptable post-
procedure quality of life.
METHODS
The study population included consecutive patients
enrolled in the ENGAGE registry from 80 sites in Western,
Central, and Eastern Europe, Asia, South Africa, the Mid-
dle East, Latin America, and Canada. The patients were
divided in two groups: those aged 80 years (274; 22.8%)
and those 80 years (926; 71.2%). Information on study
design, the Endurant stent graft system, data collection,
monitoring, and statistical methods has been published
previously.7 In short, patients were enrolled in the registry
on an intention-to-treat manner. Protocol-defined inclu-
sion criteria included age 18 years or minimum age as
required by local regulations and indication for elective
surgical repair of AAA with an endovascular stent graft in
accordance with the applicable guidelines on endovascular
interventions and the instructions for use for the Endurant
stent graft system.8 A signed consent form was obtained
from all patients. Patients were excluded if they had a high
probability of nonadherence to physician’s follow-up re-
quirements or when they were participating in a concurrent
trial that could confound the study results. The study is
registered on http://clinicaltrials.gov (NCT00870051).
Study data were recorded by the participating hospitals
on electronic case forms. Preoperative risk assessment con-
sisted of American Society of Anesthesiologists (ASA) clas-
sification and Society of Vascular Surgery/International
Society of Vascular Specialists (SVS/ISVS) scores. Baseline
comorbidities (hypertension, hyperlipidemia, diabetes,
cancer, cardiac disease, tobacco use, and renal insufficiency)
and anatomic characteristics of the aneurysm (aneurysm
diameter, length of nonaneurysmal neck, proximal and
distal neck diameter, iliac artery diameters, and infrarenal
neck angle) were tabulated. Perioperative outcome data
included technical success of stent graft placement (defined
by successful introduction of the delivery system and de-
ployment of the device), freedom from intraoperative
death, or type I/III endoleak. A successful implantation
was defined in the absence of stent kinking or twisting,
suprarenal bare stent fracture, or stent graft malfunction
(including type I or IV endoleak). Measures assessed after
discharge included freedom from migration, graft occlu-
sion, loss of structural integrity, endoleak, aneurysm expan-
sion, major adverse device-related effects, and all-cause
mortality.
Quality of life was assessed using the EuroQoL 5-
Dimensions Questionnaire (EQ-5D) index score; a preference-
based, generic instrument that measures quality of life in
three different ways.9,10 The first part was a descriptive
system profiling a respondents’ health status in five dimen-
sions: mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression, on a scale of 1 to 3, ranging from uo problems to extreme problems. The second measure
as a 0 to 100 visual analog scale for self-rating of a
atient’s own health. The last measure reflected the utility
f the measured health profile from the perspective of the
eneral population, termed the “composite EQ-5D in-
ex.” Ratings took place at the first contact (baseline), at
ischarge, and at the 30-day outpatient visit. Differences
ere measured at baseline, discharge, and at 30 days,
omparing values between groups at each time point and
ithin groups between baseline and each of the two post-
perative time points.
Statistical analysis. Differences between continuous
ariables were tested with Student’s two-tailed test except
or hospital stay, procedural stay, and intensive care unit
ICU) time, where Wilcoxon rank-sum test was applied.
ormally distributed continuous variables are expressed as
ean  standard deviation, while skewed variables are
xpressed as median and interquartile range. For categori-
al data, the Cochran-Mantel-Haenzel test was used. With-
n-group change from baseline in each EQ-5D dimension
as tested using the Stuart-Maxwell test. Two-tailed P
alues were used throughout, and significance was assumed
hen the P value was .05. All statistical analyses were
erformed with SAS statistical analysis software (SAS Insti-
ute, Cary, NC).
ESULTS
Baseline characteristics. From March 2009 to May
011, 1200 patients with infrarenal AAAs were enrolled in
he ENGAGE registry and treated with an Endurant stent
raft. The baseline characteristics are shown in Table I. The
ean age was 70.1  6.5 in the 926 patients aged 80 and
elow and 83.3  2.9 years in the 274 older patients.
ender was unequally distributed, with more female pa-
ients among the octogenarians (P  .043). The primary
ndication for stent graft placement was similar in both
roups. Octogenarians had a significantly higher ASA clas-
ification (P .001), whereas the younger cohort wasmore
ikely to smoke (P  .001) and consume alcohol (P 
005). As expected, octogenarians differed significantly in the
ccurrence of age-dependent risk factors, with an increased
ncidence of renal insufficiency and cerebrovascular/
eurological disease. Interestingly, cardiac status and pul-
onary status were evenly distributed between the two
roups.
Anatomic characteristics. Anatomic details are shown
n Table II. Octogenarians had a significantly larger aneu-
ysm (62.0  11.7 mm vs 59.9  11.6 mm; P  .010),
reater infrarenal neck angulation (33.5  24.2 vs 29.2 
3.8; P  .010), and significantly larger left iliac arteries
14.3  3.6 vs 13.6  3.6; P  .017).
Initial procedural data and hospital stay. There are
ome interesting statistical differences between the proce-
ural data of the two cohorts. General anesthesia was
mployed more often in octogenarians (P  .028). The
uration of implant procedure was significantly higher in
he elderly cohort (P  .001), which may have contrib-
ted to a longer hospital (P  .001) and postprocedure
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Volume 56, Number 1 Pol et al 29stay (P  .001). The technical success rate was equal in
both groups (Table III). The 30-day all-cause mortality
was comparable between the two groups, with 12 deaths
(1.3%) in the cohort aged 80 years and four deaths
(1.5%) among the octogenarians (P  .119). There was
no significant difference in major adverse events between
the two groups (P  .186). However, a higher incidence
of myocardial infarction (2.6% vs 0.8%; P  .015) and
procedural blood loss of 1000 mL or more (2.6% vs
1.2%; P  .102) was observed in the octogenarian group
(Table IV). After 30 days, there was no difference in the
number of secondary endovascular procedures or aneu-
rysm rupture. Although there was a slightly higher inci-
dence of conversion to open surgery in the elderly group
(0.4% vs 0%), this did not reach statistical significance
(Table IV). Except for a higher incidence of graft twist-
Table I. Baseline characteristics, risk factors, and comorbi
Baseline characteristics
Age
Gender
Female
Male 9
Primary indication for implant
Aneurysm diameter
1.5  normal infrarenal aorta
4-5 cm (0.5-cm increase in last 6 months)
5 cm 8
Other
Baseline symptoms
None 8
Abdominal pain
Back pain
Other
Risk factors
Tobacco use 5
Hypertension 7
Hyperlipidemia 6
Diabetes mellitus 2
Cancer 1
Alcoholism
Cardiac disease 5
Pulmonary disease 2
Renal insufficiency 1
Carotid artery disease 1
Cerebrovascular/neurological disease 1
Vascular disease 3
ASA classification
Class I
Class II 4
Class III 3
Class IV 1
SVS/ISVS risk level
SVS 0
SVS 1 1
SVS 2 6
SVS 3 1
ASA, American Society of Anesthesiologists; NA, not applicable; SVS/ISVS
Data are presented as means  standard deviation or percentage unless state
of ITT subjects with nonmissing values. One subject can report more than
denominator.ing (P  .01), there were no differences in the rate of hinking, stent fracture, or other malfunctions up to 30
ays of follow-up. There was, however, a significantly
igher incidence of type I endoleak in the octogenarian
roup (P  .001; Table V).
Quality of life. Quality of life data are displayed in
able VI for quality of life data between groups at each of
he three time points (intergroup differences) and within
ach group from preoperative baseline to discharge and 30
ays (intragroup differences). At the preoperative baseline
ssessment, quality of life was similar in the octogenarian
nd the younger patient group, both with respect to scor-
ng of overall state of health (P  .980) and the composite
Q-5D index (P .346). Dimensions of health status were
lso similar between the two groups with respect to the
evel of usual activities (P  .070), pain/discomfort (P 
692), and anxiety/depression (P  .228). Octogenarians,
80 years
 926)
Age 80 years
(n  274) P value
.1  6.5 83.3  2.9 NA
.043
(86/926) 13.5% (37/274)
(840/926) 86.5% (237/274)
.029
(28/926) 2.6% (7/274)
(70/926) 2.9% (8/274)
(805/926) 93.1% (255/274)
(23/926) 1.5% (4/274)
(778/926) 86.5% (237/274) .318
(92/926) 9.5% (26/274) .828
(56/926) 3.3% (9/274) .076
(23/926) 2.9% (8/274) .690
(508/905) 24.6% (65/264) .001
(699/912) 73.1% (198/271) .227
(560/874) 55.1% (140/254) .010
(185/912) 15.1% (41/271) .058
(178/913) 22.5% (60/267) .287
(33/901) 0.4% (1/266) .005
(498/925) 55.5% (152/274) .633
(231/908) 25.5% (69/271) .995
(130/916) 20.1% (55/273) .017
(82/767) 12.0% (28/233) .571
(111/925) 16.8% (46/274) .039
(296/925) 31.0% (85/274) .760
.001
(55/924) 1.8% (5/273)
(407/924) 35.9% (98/273)
(367/924) 48.7% (133/273)
(95/924) 13.6% (37/273)
NA
(1/888) 0.0% (0/267)
(155/888) 0.0% (0/267)
(592/888) 0.0% (0/267)
(140/888) 100.0% (267/267)
ty of Vascular Surgery/International Society of Vascular Specialists.
erwise. P values .05 were considered statistically significant. n  Number
baseline symptom, hence the sum of all the counts can be more than thedity
Age
(n
70
9.3%
0.7%
3.0%
7.6%
6.9%
2.5%
4.0%
9.9%
6.0%
2.5%
6.1%
6.6%
4.1%
0.3%
9.5%
3.7%
3.8%
5.4%
4.2%
0.7%
2.0%
2.0%
6.0%
4.0%
9.7%
0.3%
0.1%
7.5%
6.7%
5.8%
, Socie
d othowever, scored themselves lower than younger patients in
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July 201230 Pol et althe dimensions of baseline mobility (P  .046) and self-
care (P  .001).
At discharge, both groups scored themselves lower in
all health status dimensions compared with their preopera-
tive baseline, except for anxiety/depression, which was
improved over baseline in the younger group (P  .001)
and similar to baseline in the octogenarians (P  .241).
Compared with younger patients, octogenarians had de-
creased self-care perceptions at discharge (P  .041). The
discharge health state and composite EQ-5D were not
significantly different between the octogenarians and the
younger group (P  .093 and P  .063, respectively), and
did not differ between the two groups at the time of
discharge from their baselines (P  .999 and P  .500,
respectively).
At 30 days after operation, recovery was seen in both
age groups in mobility and pain/discomfort. However,
both the octogenarians and younger group had persistent
decreases in self-care (P .029 and P .011, respectively)
and the usual activities (P  .003 and P  .004, respec-
tively) dimension compared with preoperative baseline.
The younger patients had lessened anxiety/depression
(P  .001) versus their baseline, while the octogenarian
group did not display a similar level of improvement in this
dimension (P  .746). Compared with younger patients,
the octogenarians had a lower composite EQ-5D index
(P  .003), and they scored themselves lower in the mo-
bility (P  .001), usual activities (P  .001), and self-care
(P .001) dimensions at 30 days when compared with the
younger group. There were no significant intergroup dif-
ferences despite the 30-day overall health state (P .090).
There were no intragroup differences in the composite
EQ-5D index between baseline and 30 days (P  .163) or
between discharge and 30 days (P .392) in either group.
Octogenarians scored their baseline state of health to
Table II. Anatomical details
Aneurysm measurements
Age 80
years
(n  926)
Age 80
years
(n  274) P value
Maximum diameter of
aneurysm (mm) 59.9  11.6 62.0  11.7 .010
Proximal neck diameter
(mm) 23.8  3.6 23.8  3.6 .965
Distal neck diameter
(mm) 24.9  4.1 24.9  3.9 .952
Length of nonaneurysmal
aortic neck (mm) 27.0  12.5 27.5  12.4 .625
Distal diameter of
nonaneurysmal neck of
right iliac artery (mm) 14.2  4.0 14.5  3.7 .201
Distal diameter of
nonaneurysmal neck of
left iliac artery (mm) 13.6  3.6 14.3  3.6 .017
Infrarenal neck angle (°) 29.2  23.8 33.5  24.4 .010
Data are presented as mean standard deviation, unless stated otherwise. P
values .05 were considered statistically significant.be the same as the younger patients (P  .980), and small eifferences at discharge and 30 days did not attain statistical
ignificance (P  .063 and P  .090, respectively). By
ontrast, the composite EQ-5D index, while similar in the
wo groups at baseline and at discharge, was significantly
ower in octogenarians than younger patients at 30 days
P  .003). In summary, recovery of quality of life mea-
ured appeared to occur sooner in those patients below age
0.
ISCUSSION
This study demonstrates that octogenarians can safely
e treated by EVAR with a 30-day mortality rate of 2%.
lacement of the Endurant stent graft had a technical
uccess rate of more than 99% in both groups, and there was
o difference in the number of secondary endovascular
rocedures or conversion to open surgery between groups.
hese results compare well with the existing literature on
VAR in octogenarians, including the Eurostar regis-
ry.1,3,11-16 The 30-day mortality rate is at the low end of
he spectrum reported previously, possibly reflecting im-
rovements in devices and the perioperative care of octo-
enarians.
An interesting but previously reported finding is the
reater aneurysm diameter and increased neck angulation
n octogenarians, suggesting that treatment of the disease
ccurs at a more advanced stage in elderly patients.3 The
nfrarenal neck angle of octogenarians was 29 24 degrees
ersus 34  24 degrees for the younger cohort, and one
ay wonder whether such small differences play a funda-
ental role in daily practice. Octogenarians had higher
SA classifications and a higher prevalence of renal impair-
ent. Advanced stage abdominal aneurysms have been
roven less suitable for EVAR, with increased rates of
neurysm-related death, all-cause mortality, and rupture.17
espite somewhat more complex aortic anatomy and more
omorbidities, octogenarians had early postoperative out-
omes quite similar to that of the younger patients. Hypo-
hetically, it would appear that, assuming they always have
arger aneurysms and more angulated necks, octogenarians
re actually less suitable for EVAR, which is supported by
he observation that a correction of type I endoleak was
ore frequently required in octogenarians. However,
hereas frequent and accurate monitoring for endoleak
evelopment or stent graft migration is essential after
VAR in a younger population, these are of much less
mportance in the elderly with a natural limited life expec-
ancy. This is further confirmed by the reported results after
VAR of an annual rate of aneurysm-related death of large
neurysms of 1% in the first 3 years, which accelerated to
.0% in the 4th year, which shows that the risk increases
nly slowly over time.17 In the present study, anatomical
ifferences did not lead to a lower technical success rate or
n increased need for early secondary interventions in oc-
ogenarians. Studies with a prolonged follow-up could
urther elucidate this anatomical debate in the elderly.
In this study, a relatively high percentage of general
nesthesia was used. Many clinicians prefer local anesthesia,
specially in patients at increased surgical risk. Various
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Volume 56, Number 1 Pol et al 31studies show that general anesthesia for EVAR is associated
with increased postoperative length of hospital and ICU
stay and more morbidity.18-20 Speculatively, greater use of
local anesthesia might be predicted to reduce morbidity,
length of hospitalization, and possibly time to recovery of
normal activities. In octogenarians, although not contrib-
uting to more major adverse events in the octogenarian
Table III. Initial procedural data and hospital stay
Measurement
Type of anesthesia
General
Spinal
Epidural
Local
Duration of implant procedure (minutes)
Estimated blood loss during procedure (cc)
Evaluation of Endurant
Endurant stent graft successfully delivered
Endurant stent graft successfully deployed
Total hospital stay (days)
Postprocedure stay (days)
Duration of intensive care unit stay (hours)
Intraoperative clinical success
Technical success
Freedom from intraoperative death 1
Freedom from type I/III endoleak (uncorrected)
Data are presented as mean  standard deviation or percentage, unless st
hospital stay (days)  date of hospital discharge – date of hospital admiss
overall hospital stay will be considered to be 0.5 day. Procedural hospital
where date of hospital discharge  date of initial procedure, procedural
Table IV. Early outcome
Event
A
All-cause mortality 1
One or more major adverse events 3
All-cause mortality 1
Bowel ischemia 0
Myocardial infarction 0
Paraplegia 0
Procedural blood loss 1000 mL 1
Renal failure 0
Respiratory failure 0
Stroke 0
Intraoperative
Conversion to open surgery 0
Aneurysm rupture 0
Secondary endovascular procedure 0
Secondary endovascular procedure to correct
type I/III endoleak 0
1-30 days
Conversion to open surgery 0
Aneurysm rupture 0
Secondary endovascular procedure to correct
type I/III endoleak 0
Secondary endovascular procedure 1
NA, Not applicable.
P values .05 were considered statistically significant.group, both the duration of the procedure and operative tlood loss were higher compared with younger patients.
he main reason for this observation may relate to the less
avorable anatomy of the aneurysms in the older group. But
espite the higher frequency of adverse events, this did not
each statistical significance, and the rate is considerably less
han what has been reported after open surgical repair.15
This is one of the few studies that specifically evaluated
80 years
 926)
Age 80 years
(n  274) P value
(563/926) 68.1% (186/273) .028
(211/926) 19.0% (52/273) .190
(81/926) 6.6% (18/273) .256
(118/926) 10.3% (28/273) .270
7  45.3 107.8  42.8 .001
4  214.3 233.9  246.6 .049
(920/926) 99.6% (273/274) .589
(920/926) 99.6% (273/274) .589
3  6.44 7.33  6.00 .0001
9  4.90 5.66  5.49 .0001
8  48.7 8.0  17.3 .8543
(903/926) 98.2% (269/274) .526
(917/926) 99.3% (272/274) .712
(926/926) 100.0% (274/274)
(907/921) 98.9% (270/273) .606
therwise. P values .05 were considered statistically significant. Overall
the case where date of hospital discharge  date of hospital admission,
days)  date of hospital discharge – date of initial procedure. In the case
tal stay will be considered to be 0.5 day.
80 years
926)
Age 80 years
(n  274) P value
2/926) 1.5% (4/274) .835
4/926) 5.5% (15/274) .186
2/926) 1.5% (4/274)
/926) 0.4% (1/274)
/926) 2.6% (7/274)
/926) 0.0% (0/274)
1/926) 2.6% (7/274)
/926) 0.0% (0/274)
/926) 0.0% (0/274)
/926) 0.4% (1/274)
/926) 0.0% (0/274) .442
/926) 0.0% (0/274) .586
/926) 0.4% (1/274) .066
/926) 0.0% (0/274) NA
/926) 0.4% (1/274) .066
/926) 0.0% (0/274) .586
/926) 0.7% (2/274) .195
4/926) 1.5% (4/274) .950Age
(n
60.8%
22.8%
8.7%
12.7%
97.
203.
99.4%
99.4%
6.0
4.4
10.
97.5%
99.0%
00.0%
98.5%
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July 201232 Pol et aldata document significant differences in preoperative qual-
ity of life with reduced perceptions of mobility, usual activ-
ity, and self-care in the octogenarians. While there was
some delay in quality of life recovery in the older patients,
specifically with regard to usual activities at 30 days, most
elements of health status had recovered to baseline. Inter-
estingly, the younger patients had reductions in the level of
their anxiety/depression at discharge and 30 days, while
older patients maintained their baseline levels through 30
days.
The length of recovery to baseline functional level
attains particular importance in octogenarians with more
limited life expectancy. Prior studies have shown that
patient-reported health-related quality of life after EVAR is
significantly impaired in the early postoperative period but
returns to baseline by 6 months.21 Another study docu-
mented reduced mobility/physical ability among the el-
derly.22 Our results are similar to the findings of prior work,
but the current data suggest that the recovery may occur
early, even within 30 days. The three major randomized
controlled trials (EVAR 1 and 2 and the Dutch Ran-
domised Endovascular AneurysmManagement [DREAM]
trial) comparing EVAR and open repair reported conflict-
ing results on outcome of quality of life.23-25 For instance,
EVAR 1 found a significant difference in favor of EVAR
after the first month, which canceled out after longer
follow-up. The DREAM trial found comparable results
after 30 days but a significant difference after 6 months in
favor of open repair. This last outcome is not unique and
has also more recently been shown.21 A systemic review in
order to compare utility outcomes between EVAR and
open repair was unable to reach a clear conclusion due to
the low number of studies and inconsistent findings.26
Several individual institutional studies on the other hand
Table V. Initial stent graft outcome
Event
Age 80
(n  9
Stent graft kinking 0.9% (8/
Stent graft twisting 0.2% (2/
Stent graft wire form fracture 0.0% (0/
Suprarenal bare stent fracture 0.0% (0/
Additional stent graft malfunction(s) 0.3% (3/
Endoleak (corrected) 7.3% (67
Type I 4.6% (42
Type II 2.0% (18
Type III 0.7% (6/
Type IV 0.1% (1/
Undetermined 0.1% (1/
Endoleak (uncorrected) 15.4% (14
Type I 1.1% (10
Type II 11.8% (10
Type III 0.4% (4/
Type IV 1.4% (13
Undetermined 1.0% (9/
NA, Not applicable.
P values .05 were considered statistically significant.report a similar effect on quality of life after EVAR or open aepair.27,28 These conflicting results make an adequate
omparison with open repair difficult.
The current study has some limitations. Even though
he registry had limited inclusion/exclusion criteria and
rocedural specifications, all patients included were suitable
or elective surgical repair of AAAs with an endovascular
tent graft. It is known from current literature that many
AAs are anatomically unsuitable for endovascular re-
air.29,30 This inevitably has led to a selection bias of
natomically suitable, and therefore preferable, aneurysms.
ecently, it has been shown that the reduction in mortality
etween EVAR and open repair in an acute setting is
nlikely to be from a selection bias based on anatomic AAA
onfiguration alone.31 Whether this relation with anatom-
cal suitability also applies in an elective setting has yet to be
etermined. Moreover, the current data were derived from
n observational, noninterventional study, and therefore it
ay not be excluded that in certain octogenarians treat-
ent was refused, thereby possibly inducing a selection
ias. There also was a difference in gender between octo-
enarians and the younger cohort. Whether this difference
as affected the results may not be concluded from the
resent data.
In the present study, 1.8% (five out of 274) of the
ctogenarians had an aneurysm diameter smaller than 5.5
m. Although this does not match with the internationally
ccepted indications for intervention, we do not believe
hat this either positively or negatively has affected the
utcome. Moreover, this small group of patients also in-
luded those with a rapid aneurysmal growth (5 mm in
ast 6 months) justifying surgical intervention, also in octo-
enarians.
Importantly, the current study has follow-up to 30 days
nly. The 30-day morbidity and mortality rate, however, is
s Age 80 years
(n  273) P value
1.5% (4/272) .384
1.5% (4/272) .010
0.0% (0/272) NA
0.0% (0/272) NA
0.4% (1/273) .919
) 14.7% (40/273) .001
) 12.1% (33/273) .001
) 2.2% (6/273) .807
0.4% (1/273) .589
0.0% (0/273) .586
0.4% (1/273) .361
1) 19.4% (53/273) .117
) 1.1% (3/273) .985
1) 16.1% (44/273) .064
0.0% (0/273) .276
) 2.6% (7/273) .193
0.0% (0/273) .101year
21)
919)
918)
919)
919)
921)
/921
/921
/921
921)
921)
921)
2/92
/921
9/92
921)
/921
921)widely accepted time frame for early postoperative com-
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Event
Age 80 years
(n  926)
Age 80 years
(n  274) P value
Baseline
Mobility .046
1 (no problem) 70.8% (627/886) 63.6% (168/264)
2 (some problems) 28.4% (252/886) 36.0% (95/264)
3 (extreme problems) 0.8% (7/886) 0.4% (1/264)
Self-care .001
1 (no problem) 92.9% (823/886) 84.1% (222/264)
2 (some problems) 6.0% (53/886) 14.0% (37/264)
3 (extreme problems) 1.1% (10/886) 1.9% (5/264)
Usual activities .070
1 (no problem) 81.9% (726/886) 76.1% (201/264)
2 (some problems) 15.6% (138/886) 21.2% (56/264)
3 (extreme problems) 2.5% (22/886) 2.7% (7/264)
Pain/discomfort .692
1 (no problem) 65.8% (583/886) 64.0% (169/264)
2 (some problems) 31.3% (277/886) 33.3% (88/264)
3 (extreme problems) 2.9% (26/886) 2.7% (7/264)
Anxiety/depression .228
1 (no problem) 72.5% (642/886) 75.8% (200/264)
2 (some problems) 24.2% (214/886) 22.0% (58/264)
3 (extreme problems) 3.4% (30/886) 2.3% (6/264)
Your own health state today (0: bad
to 100: excellent) 72.8  16.9 72.8  16.4 .980
Median (IQR) 75.0 (0.81-1.00) 75.0 (0.79, 1.00)
EQ-5D index 0.86  0.17 0.85  0.17 .346
Median (IQR) 0.85 (0.81-1.00) 0.84 (0.79-1.00)
At discharge
Mobility .073
1 (no problem) 55.1% (425/772) 48.9% (110/225)
2 (some problems) 43.4% (335/772) 48.4% (109/225)
3 (extreme problems) 1.6% (12/772) 2.7% (6/225)
Self-care .062
1 (no problem) 76.3% (588/771) 71.6% (161/225)
2 (some problems) 22.3% (172/771) 24.9% (56/225)
3 (extreme problems) 1.4% (11/771) 3.6% (8/225)
Usual activities .041
1 (no problem) 61.7% (476/772) 52.9% (119/225)
2 (some problems) 32.0% (247/772) 40.0% (90/225)
3 (extreme problems) 6.3% (49/772) 7.1% (16/225)
Pain/discomfort .385
1 (no problem) 46.0% (355/771) 42.7% (96/225)
2 (some problems) 51.5% (397/771) 54.7% (123/225)
3 (extreme problems) 2.5% (19/771) 2.7% (6/225)
Anxiety/depression .739
1 (no problem) 80.9% (624/771) 80.4% (181/225)
2 (some problems) 17.9% (138/771) 17.8% (40/225)
3 (extreme problems) 1.2% (9/771) 1.8% (4/225)
Your own health state today (0: bad
to 100: excellent) 71.8  15.9 69.7  16.8 .093
Median (IQR) 70.0 (60-82) 70.0 (60-80)
EQ-5D index 0.81  0.18 0.78  0.18 .063
Median (IQR) 0.83 (0.74-1) 0.81 (0.71-86)
Change from baseline to discharge 0.05  0.17 0.06  0.17 .500
Median (IQR) 0.00 (0.16-0) 0.01 (0.17-0)
After 30 days
Mobility .001
1 (no problem) 68.4% (523/765) 54.3% (125/230)
2 (some problems) 30.8% (236/765) 43.0% (99/230)
3 (extreme problems) 0.8% (6/765) 2.6% (6/230)
Self-care .001
1 (no problem) 90.1% (689/765) 77.8% (179/230)
2 (some problems) 8.9% (68/765) 17.8% (41/230)
3 (extreme problems) 1.0% (8/765) 4.3% (10/230)
R1
d oth
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July 201234 Pol et alplications. As octogenarians are considered to be frailer
when compared to younger patients, an increased compli-
cation rate may have been expected, which subsequently
could have affected their early quality of life. Early
quality of life, in turn, is extremely important for the
elderly, as their life expectancy is short. The ideal time
frame of quality of life assessment after EVAR is un-
known and clearly, longer-term data of at least 12
months will be necessary to more fully elucidate patient
morbidity, quality of life issues, and the interplay be-
tween the two.
CONCLUSIONS
Octogenarians can safely undergo EVAR with a high
rate of technical success, low short-term morbidity and
mortality, and good recovery of quality of life indexes by
the 30-day postoperative time point. This age group ap-
pears ideal for treatment with stent graft repair in those with
appropriately sized aneurysms and anatomy suitable for an
endovascular solution.
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Table VI. Continued.
Event
Age 80
(n  92
Usual activities
1 (no problem) 76.6% (586/
2 (some problems) 20.9% (160/
3 (extreme problems) 2.5% (19/7
Pain/discomfort
1 (no problem) 65.6% (502/
2 (some problems) 32.4% (248/
3 (extreme problems) 2.0% (15/7
Anxiety/depression
1 (no problem) 80.5% (616/
2 (some problems) 18.4% (141/
3 (extreme problems) 1.0% (8/76
Your own health state today (0: bad
to 100: excellent) 76.0 
Median (IQR) 80.0 (70-90
EQ-5D index 0.87 
Median (IQR) 0.85 (0.81-
Change from baseline to 30 days 0.01 
Median (IQR) 0.00 (0.0
Change from discharge to 30 days 0.06 
Median (IQR) 0.01 (0.6
IQR, Interquartile range.
Data are presented as mean  standard deviation or percentage, unless stateOverall responsibility: MREFERENCES
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Endovascular aneurysm repair (EVAR) is being used for patients
that are older and sicker. Giles et al1 previously published a Medicare
database analysis demonstrating a significantly increased risk of mor-
bidity and mortality in the octogenarian age group that is more
pronounced for open abdominal aortic aneurysm repair compared
with EVAR. Another recent study by Goldstein et al2 reported the
safety of treating the nonagenarian patient with EVAR.
So, what should we do as treating physicians in counseling
older patients about the safety of EVAR and their ability to return
to their current lifestyle? The current study used the Endurant
Stent Graft Natural Selection Global Postmarket (ENGAGE)
worldwide registry to assist with answering this question. Pol et al
investigated multiple aspects of EVAR from this registry, in-
cluding anatomic features, technical outcomes, and a quality-
of-life analysis for patients treated with the Endurant stent graft
system (Medtronic, Santa Rosa, Calif). Their goal was to compare
the octogenarian population with patients aged 80 years from
the ENGAGE database, assessing early outcomes at 30 days. The
authors were able to demonstrate some minor anatomic differ-
ences between the younger and older patient groups, with slightly
more complex anatomy in the octogenarians, but with no technical
differences in outcomes. The quality-of-life assessment did show
some minor differences, however, with the octogenarians having a
slower recovery at 30 days.ent to the average patient, because the anatomic and patient
haracteristic restrictions of a clinical trial are not present in this
tudy. The octogenarian patients did very well in the success of
epair, despite the slightly more difficult aortic neck anatomy.
here was also no significant difference in the need for any second-
ry interventions. Most important, the quality-of-life assessment
as relatively comparable in both age groups.
I would like to add some words of caution. The data 6
onths will be very interesting. I am concerned that some of the
natomic differences may becomemore apparent with the need for
econdary interventions at the 6-month or 1-year evaluations, and
am even more interested in the quality-of-life assessment. How
o the octogenarians compare with younger patients at 6 months?
nly the data can answer this question, and I look forward to a
ollow-up study.
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